Featured Articles

The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study

Reverberating Toll

COVID-19 in hidradenitis suppurativa patients

Clinical and demographic features of hidradenitis suppurativa: A multicenter study of 1221 patients with an analysis of risk factors associated with disease severity